Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 28.57 $ 0.05 (0.18 %)    

Friday, 06-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 28.56
$ 28.57 x 1,253
$ 28.58 x 1,200
-- - --
$ 24.48 - $ 32.71
31,214,484
na
161.84B
$ 0.54
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-08-2023 10-01-2023 10-Q
5 08-09-2023 07-02-2023 10-Q
6 05-10-2023 04-02-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-09-2022 10-02-2022 10-Q
9 08-10-2022 07-03-2022 10-Q
10 05-11-2022 04-03-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-12-2021 10-03-2021 10-Q
13 08-12-2021 07-04-2021 10-Q
14 05-13-2021 04-04-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-27-2020 10-Q
17 08-06-2020 06-28-2020 10-Q
18 05-07-2020 03-29-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-07-2019 09-29-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 07-01-2018 10-Q
26 05-10-2018 04-01-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 11-09-2017 10-01-2017 10-Q
29 08-10-2017 07-02-2017 10-Q
30 05-11-2017 04-02-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-10-2016 10-02-2016 10-Q
33 08-11-2016 07-03-2016 10-Q
34 05-12-2016 04-03-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-05-2015 09-27-2015 10-Q
37 08-06-2015 06-28-2015 10-Q
38 05-07-2015 03-29-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-06-2014 09-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bicycle-therapeutics-lead-cancer-candidates-has-high-opportunity-analyst-initiates-with-bullish-tone
Bicycle Therapeutics' Lead Cancer Candidat...
09/06/2024 17:37:16

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safe...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

whats-going-on-with-penny-stock-blood-cancer-focused-vor-biopharma-on-friday
What's Going On With Penny Stock Blood Can...
09/06/2024 13:35:08

Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern
Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

psychedelic-drugs-market-set-to-grow-by-137b-by-2028-driven-by-mental-health-disorders-and-ai-integration
Psychedelic Drugs Market Set To Grow By $1...
09/05/2024 16:53:46

The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI adva...

ascendis-pharma-faces-challenges-with-skytrofa-and-yorvipath-pricing-analysts-weigh-in
Ascendis Pharma Faces Challenges With Skyt...
09/04/2024 21:02:35

Ascendis Pharma reported disappointing Q2 sales of $38.76 million, missing the consensus of $92.7 million. Key updates included...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

acepodia-enters-strategic-clinical-collaboration-with-pfizer-ignite-to-support-development-of-its-therapies-in-autoimmune-diseases
Acepodia Enters Strategic Clinical Collabo...
09/03/2024 21:04:34

Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its c...

uk-taiwan-approve-modernas-updated-covid-19-shot
UK, Taiwan Approve Moderna's Updated COVID...
09/03/2024 18:39:51

The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 ...

pfizer-and-valneva-partnered-lyme-disease-vaccine-shows-effectiveness-as-booster-shot-in-mid-stage-study
Pfizer And Valneva Partnered Lyme Disease ...
09/03/2024 18:37:07

Valneva and Pfizer released data from their Phase 2 study of the Lyme disease vaccine candidate VLA15, showing strong immune re...

vaxcyte-shoals-technologies-polestar-automotive-applied-optoelectronics-and-other-big-stocks-moving-higher-on-tuesday
Vaxcyte, Shoals Technologies, Polestar Aut...
09/03/2024 14:47:56

bacterial-infections-vaccine-developer-vaxcytes-pneumococcal-shot-shows-promise-in-mid-stage-trial-stock-shoots-higher
Bacterial Infections Vaccine Developer Vax...
09/03/2024 13:40:49

Vaxcyte announced positive topline results from its Phase 1/2 study of VAX-31, a 31-valent pneumococcal conjugate vaccine candi...

Core News & Articles
Valneva And Pfizer Announced Further Immun...
09/03/2024 09:39:04

The immune response and safety profile of VLA15 one month after receiving the second booster dose were similar to those reporte...

why-is-bridgebio-pharma-stock-trading-higher-on-friday
Why Is BridgeBio Pharma Stock Trading High...
08/30/2024 17:10:49

BridgeBio Pharma presented additional data from its Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM at the European Society...

alnylam-pharmaceuticals-stock-falls-after-detailed-vutrisiran-data-for-a-condition-with-stiff-heart-muscles
Alnylam Pharmaceuticals Stock Falls After ...
08/30/2024 13:51:46

Alnylam Pharmaceuticals shares drop as detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR-CM reveal mixed ...

a-closer-look-at-pfizers-options-market-dynamics
A Closer Look at Pfizer's Options Market D...
08/29/2024 14:46:41

reported-earlier-flagship-pioneering-expands-strategic-partnership-with-pfizer-through-two-new-research-programs-with-quotient-therapeutics-focusing-on-somatic-mutations-for-cardiovascular-and-renal-disease-therapies-latest-initiative-under-july-2023-collaboration
Reported Earlier: Flagship Pioneering Expa...
08/28/2024 14:45:32

pfizer-launches-pfizerforall-streamlining-healthcare-access-with-a-comprehensive-digital-platform
Pfizer Launches PfizerForAll, Streamlining...
08/27/2024 10:48:17

PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for p...

americans-to-access-covid-19-test-kits-for-free-as-us-government-restarts-free-at-home-program
Americans To Access COVID-19 Test Kits For...
08/26/2024 15:24:26

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall ...

novo-nordisks-ozempic-might-be-among-2027-medicare-price-negotiation-targets
Novo Nordisk's Ozempic Might Be Among 2027...
08/23/2024 18:21:18

Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite co...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION